Effects of the Antidepressant Fluoxetine on the Subcellular Localization of 5-HT1A Receptors and SERT

Overview

Journal Philos Trans R Soc Lond B Biol Sci

Specialty Biology

Date 2012 Jul 25

PMID 22826342

Citations 36

Authors

Laurent Descarries

Mustaph Riad

Affiliations

Soon will be listed here.

Abstract

Serotonin (5-HT) 5-HT(1A) autoreceptors (5-HT(1A)autoR) and the plasmalemmal 5-HT transporter (SERT) are key elements in the regulation of central 5-HT function and its responsiveness to antidepressant drugs. Previous immuno-electron microscopic studies in rats have demonstrated an internalization of 5-HT(1A)autoR upon acute administration of the selective agonist 8-OH-DPAT or the selective serotonin reuptake inhibitor antidepressant fluoxetine. Interestingly, it was subsequently shown in cats as well as in humans that this internalization is detectable by positron emission tomography (PET) imaging with the 5-HT(1A) radioligand [(18)F]MPPF. Further immunocytochemical studies also revealed that, after chronic fluoxetine treatment, the 5-HT(1A)autoR, although present in normal density on the plasma membrane of 5-HT cell bodies and dendrites, do not internalize when challenged with 8-OH-DPAT. Resensitization requires several weeks after discontinuation of the chronic fluoxetine treatment. In contrast, the SERT internalizes in both the cell bodies and axon terminals of 5-HT neurons after chronic but not acute fluoxetine treatment. Moreover, the total amount of SERT immunoreactivity is then reduced, suggesting that SERT is not only internalized, but also degraded in the course of the treatment. Ongoing and future investigations prompted by these finding are briefly outlined by way of conclusion.

Citing Articles

Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures.

Yao H, Wang X, Chi J, Chen H, Liu Y, Yang J Molecules. 2024; 29(5).

PMID: 38474476 PMC: 10934989. DOI: 10.3390/molecules29050964.

Therapeutic treatment with fluoxetine using the chronic unpredictable stress model induces changes in neurotransmitters and circulating miRNAs in extracellular vesicles.

Estevez-Cabrera M, Sanchez-Munoz F, Perez-Sanchez G, Pavon L, Hernandez-DiazCouder A, Cortes Altamirano J Heliyon. 2023; 9(2):e13442.

PMID: 36852042 PMC: 9958461. DOI: 10.1016/j.heliyon.2023.e13442.

Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments.

Richardson B, MacPherson A, Bambico F Brain Behav Immun Health. 2022; 26:100554.

PMID: 36388140 PMC: 9663329. DOI: 10.1016/j.bbih.2022.100554.

Accelerated HF-rTMS Modifies SERT Availability in the Subgenual Anterior Cingulate Cortex: A Canine [C]DASB Study on the Serotonergic System.

Xu Y, Kappen M, Peremans K, De Bundel D, Van Eeckhaut A, Van Laeken N J Clin Med. 2022; 11(6).

PMID: 35329857 PMC: 8950510. DOI: 10.3390/jcm11061531.

G-protein coupled receptors and synaptic plasticity in sleep deprivation.

Parmar S, Tadavarty R, Sastry B World J Psychiatry. 2021; 11(11):954-980.

PMID: 34888167 PMC: 8613756. DOI: 10.5498/wjp.v11.i11.954.

References

Pineyro G, Blier P, Dennis T, De Montigny C . Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci. 1994; 14(5 Pt 2):3036-47. PMC: 6577511. View

Stockmeier C, Dilley G, Shapiro L, Overholser J, Thompson P, Meltzer H . Serotonin receptors in suicide victims with major depression. Neuropsychopharmacology. 1997; 16(2):162-73. DOI: 10.1016/S0893-133X(96)00170-4. View

Czachura J, Rasmussen K . Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol. 2000; 362(3):266-75. DOI: 10.1007/s002100000290. View

Cremers T, Spoelstra E, de Boer P, Bosker F, Mork A, den Boer J . Desensitisation of 5-HT autoreceptors upon pharmacokinetically monitored chronic treatment with citalopram. Eur J Pharmacol. 2000; 397(2-3):351-7. DOI: 10.1016/s0014-2999(00)00308-3. View

Iceta R, Mesonero J, Alcalde A . Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells. Life Sci. 2007; 80(16):1517-24. DOI: 10.1016/j.lfs.2007.01.020. View

Sibon I, Benkelfat C, Gravel P, Aznavour N, Costes N, Mzengeza S . Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol Psychiatry. 2008; 63(12):1135-40. DOI: 10.1016/j.biopsych.2007.11.016. View

Lopez J, Chalmers D, Vazquez D, Watson S, Akil H . Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry. 1994; 35(4):287-90. DOI: 10.1016/0006-3223(94)91262-9. View

Hirano K, Seki T, Sakai N, Kato Y, Hashimoto H, Uchida S . Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain. Brain Res. 2005; 1053(1-2):154-61. DOI: 10.1016/j.brainres.2005.06.038. View

Hensler J, Kovachich G, Frazer A . A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology. 1991; 4(2):131-44. View

10.

Le Poul E, Laaris N, Doucet E, Laporte A, Hamon M, Lanfumey L . Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn Schmiedebergs Arch Pharmacol. 1995; 352(2):141-8. DOI: 10.1007/BF00176767. View

11.

Cheetham S, Crompton M, Katona C, Horton R . Brain 5-HT1 binding sites in depressed suicides. Psychopharmacology (Berl). 1990; 102(4):544-8. DOI: 10.1007/BF02247138. View

12.

Popa D, Cerdan J, Reperant C, Guiard B, Guilloux J, David D . A longitudinal study of 5-HT outflow during chronic fluoxetine treatment using a new technique of chronic microdialysis in a highly emotional mouse strain. Eur J Pharmacol. 2009; 628(1-3):83-90. DOI: 10.1016/j.ejphar.2009.11.037. View

13.

Riad M, WATKINS K, Doucet E, Hamon M, Descarries L . Agonist-induced internalization of serotonin-1a receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J Neurosci. 2001; 21(21):8378-86. PMC: 6762788. View

14.

Pejchal T, Foley M, Kosofsky B, Waeber C . Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol. 2002; 135(5):1115-22. PMC: 1573219. DOI: 10.1038/sj.bjp.0704555. View

15.

Beer M, Kennett G, Curzon G . A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur J Pharmacol. 1990; 178(2):179-87. DOI: 10.1016/0014-2999(90)90473-j. View

16.

Kreiss D, Lucki I . Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther. 1995; 274(2):866-76. View

17.

Riad M, Zimmer L, Rbah L, Watkins K, Hamon M, Descarries L . Acute treatment with the antidepressant fluoxetine internalizes 5-HT1A autoreceptors and reduces the in vivo binding of the PET radioligand [18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci. 2004; 24(23):5420-6. PMC: 6729302. DOI: 10.1523/JNEUROSCI.0950-04.2004. View

18.

Arango V, Underwood M, Gubbi A, Mann J . Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 1995; 688(1-2):121-33. DOI: 10.1016/0006-8993(95)00523-s. View

19.

Martin L, Jackson D, Wallsten C, Waszczak B . Electrophysiological comparison of 5-Hydroxytryptamine1A receptor antagonists on dorsal raphe cell firing. J Pharmacol Exp Ther. 1999; 288(2):820-6. View

20.

Hrdina P, Vu T . Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study. Synapse. 1993; 14(4):324-31. DOI: 10.1002/syn.890140410. View